Vanguard Group Inc. Boosts Holdings in Merck & Co., Inc. $MRK

robot
Abstract generation in progress

Vanguard Group Inc. significantly increased its stake in Merck & Co., Inc. (NYSE:MRK) during the 4th quarter, acquiring an additional 2.1 million shares and raising its total holdings to over 254 million shares, valued at approximately $26.77 billion. This made Vanguard Group Inc. the largest institutional holder of Merck’s stock, owning about 10.25% of the company. The article also details other institutional investor activity, Merck’s recent financial performance, dividend announcement, and recent news including partnerships for AI in drug discovery and FDA approvals, alongside some analyst forecasts and insider stock sales.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin